Short Summary
The Bombay High Court addressed the trademark infringement suit filed by Ultratech Cement against Dalmia Cement Bharat. The court formally framed seven key issues, including whether the defendant's use of 'DALMIA ULTRA' infringes upon Ultratech's registered trademarks and whether there is an act of passing off. This judgment sets the stage for detailed evidence presentation, directing the plaintiff to file affidavits within four weeks.
Detailed Summary
of the Paris Local Division of the Unified Patent Court concerning a request for extension of time filed by the Bosch defendants. The judge-rapporteur rejected Bosch's request, finding that a non-redacted version of Valeo's 15 June 2026 filing had been deposited in the CMS simultaneously with the redacted version, and that Bosch had failed to exercise due diligence in accessing it. The court ruled that the deadlines under R.29(d) RdP run from 15 June 2026.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Bombay High Court. Understanding the court's reasoning in Ultratech Cement Limited vs Dalmia Cement Bharat Limited is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Tryton Medical Inc.vsUnion Of India & Ors.
Tryton Medical Inc. challenged the refusal by the Controller of Patents to examine its National Phase Patent Application, which had been rejected due to a minor delay in filing. The petitioner argued that the Intellectual Property Appellate Board (IPAB) had previously allowed the appeal and directed the Controller to proceed with examination. The Delhi High Court ruled in favor of the petitioner, mandating compliance with the IPAB's orders.
F.Hoffmann-La Roche LtdvsMylan Laboratories Limited
F.Hoffmann-La Roche Ltd filed a petition seeking the revocation of Patent No. 205706. However, the petitioner's counsel submitted that the term of the patent had already expired on June 4, 2021.
Centaur Pharmaceuticals Pvt LtdvsBRD Medilabs & Anr
Centaur Pharmaceuticals Pvt Ltd filed a Commercial IP Suit against BRD Medilabs & Anr regarding trademark infringement. The court decreed the suit in specific terms, requiring the defendants to apply for the cancellation of their registered mark 'Sanaret Labs' and withdraw their service mark application within four weeks.
Novartis Ag & Anr.vsNatco Pharma Limited
Novartis, the patent holder of IN 276026 covering novel pyrimidine compounds including Ceritinib, alleged that Natco Pharma Limited was infringing the patent by manufacturing and selling Ceritinib under its brand NOXALK. The court found that Natco had infringed the valid suit patent.
Nokia Technologies OyvsGuangdong Oppo Mobile Telecommunications Corp Ltd & Ors.
The court addressed several counter claims filed by counterclaimants seeking the revocation of four specific Indian patents (IN 259932, IN 269929, IN 321300, and IN 300066). The order directed that the counter claims be numbered, notice issued, and written statements filed.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.